The Cigna Group

CI: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$151.00KyhgxSlwbpjyn

As Cigna Posts Strong 2Q, Fair Value Unchanged

Narrow-moat Cigna turned in strong second-quarter operating results that allowed management to boost its 2022 outlook a bit. Even after incorporating these mildly stronger near-term expectations, our $299 fair value estimate has not changed materially. Shares appear to be moving closer to fair value due to the company's operational momentum.

Sponsor Center